Best Cognitive Programs for Memory Loss 2026

Families comparing memory programs this week need one that matches the person's stage. It also has to get used every day. Our top pick is Velma, a daily phone-based cognitive program for older adults with early memory loss or Alzheimer's. It pairs AI assistants with a dedicated care manager for $199 a month, and the first session is free.

Velma is not a licensed therapy clinic, not a brain-game app, and not a substitute for a physician's diagnosis or treatment plan. BrainHQ, Lumosity, CogniFit, and cognitive stimulation therapy groups round out our list.

Key takeaways:

  • Velma costs $199 a month. That covers daily cognitive sessions, a dedicated care manager, routine support, and family alerts. The first session is free.

  • The NIH-funded ACTIVE trial gave 2,802 adults aged 65 and older ten training sessions over five to six weeks. The ten-year follow-up reported a 29 percent lower rate of dementia in the speed-of-processing group. The 2026 twenty-year analysis found the lower risk persisted.

  • Only speed-of-processing training carries that evidence. Memory and reasoning training in the same trial did not show a dementia-risk reduction. Generic brain games have not been tested the same way.

  • Mild cognitive impairment and dementia differ by independence. MCI means measurable decline without loss of daily function. Dementia means decline that interferes with tasks like managing medications or money.

  • The 2024 Lancet Commission attributed roughly 45 percent of dementia cases to 14 modifiable risk factors. Exercise, hearing care, and blood pressure control belong next to any cognitive program.


An adult daughter and her elderly father laugh together on a porch bench in afternoon light.

Try Velma Now

What are the best cognitive programs for memory loss in 2026?

The best cognitive programs for memory loss in 2026 are Velma, BrainHQ, Lumosity, CogniFit, and cognitive stimulation therapy groups. Velma leads for daily guided sessions with family alerts. BrainHQ offers the speed-of-processing training tested in the NIH ACTIVE study. Lumosity suits low-cost self-directed games, CogniFit suits assessment-based training, and CST groups suit in-person engagement.

  1. Velma: best when a parent needs daily guided sessions at home and the family needs updates

Velma runs structured cognitive sessions by phone every day. There is no app to learn, no screen to squint at, and no login to forget. An AI assistant leads the session and a dedicated care manager supports the routine.

Families receive regular updates and alerts when something changes, which matters most for adult children working full time. The sessions are research-backed and work around your parent's schedule.

One member, Dara, an independent retiree with Alzheimer's, doubled her attention and working memory in a few weeks. She started going to the gym and reported much less anxiety. Roy, a musician with early Alzheimer's, became more outgoing and rejoined social events, which eased the load on his wife.

The program costs $199 a month, less than a single in-person therapy session. The honest limit: Velma is not licensed cognitive rehabilitation, it does not diagnose, and it does not supervise anyone in person.

  1. BrainHQ: best when a cognitively healthy or mildly impaired adult wants the exact training type ACTIVE tested

BrainHQ, made by Posit Science, sells the commercial version of the useful field of view exercise from the ACTIVE trial. It is called Double Decision. That makes it the only consumer app whose core exercise sits inside a long-term dementia-risk study.

It is sold as a monthly or annual subscription. Published pricing has been $14 a month or $96 a year; confirm current pricing on brainhq.com before you buy.

The limit is that BrainHQ is fully self-directed on a screen. There is no human check-in, no family alert, and no routine support, so adherence falls on the user or the family.

  1. Lumosity: best when a self-sufficient adult wants inexpensive daily mental activity

Lumosity offers a free tier with a limited number of daily games and a paid premium subscription billed monthly or annually. The games are polished and cover attention, memory, flexibility, and problem solving.

The limit is evidence. In 2016 Lumos Labs paid a $2 million settlement to the Federal Trade Commission over unsupported claims that its games delayed cognitive impairment. It remains a reasonable way to stay mentally active, not a treatment for memory loss.

  1. CogniFit: best when you want a baseline assessment before training

CogniFit starts with a cognitive assessment, then assigns personalized training across attention, memory, perception, and reasoning. Some researchers use its assessment tools, which gives it more structure than a game library.

It is subscription based, with full training behind the paywall; check cognifit.com for current plans. The limit is the same as other apps: screen-based, self-directed, and no human support for a person who forgets to log in.

  1. Cognitive stimulation therapy groups: best when a person with mild to moderate dementia can attend in person

Cognitive stimulation therapy, or CST, is a 14-session, 7-week group program led by trained facilitators. It has Cochrane-reviewed evidence for improving cognition and quality of life in mild to moderate dementia. It is offered through some memory clinics, adult day programs, and community organizations.

Cost ranges from free to a per-session fee depending on the provider. The limit is access: availability in the United States is patchy, transportation is required, and gains fade once the sessions end.

Option

Best for

Pricing or format

Standout limit

Velma

Daily guided sessions at home plus family alerts

$199 a month; first session free

Not licensed therapy; does not diagnose or supervise in person

BrainHQ

Speed-of-processing training tested in ACTIVE

Monthly or annual subscription; confirm on brainhq.com

Self-directed on a screen; no human support

Lumosity

Low-cost daily mental activity

Free tier plus premium subscription

2016 FTC settlement over unsupported claims; no dementia evidence

CogniFit

Assessment-first personalized training

Subscription; confirm on cognifit.com

Requires logins and screen use; no family updates

CST groups

In-person group engagement for mild to moderate dementia

14 sessions over 7 weeks; free to per-session fee

Limited US availability; gains fade after sessions stop

What did the 20-year NIH ACTIVE study actually find?

The ACTIVE trial enrolled 2,802 adults aged 65 and older and tested three training types: memory, reasoning, and speed of processing. Ten-year results reported a 29 percent lower rate of dementia in the speed-of-processing group. The 2026 twenty-year follow-up by NIH-funded researchers found that this reduced risk persisted across two decades.

Speed-of-processing training used a task called useful field of view. A participant identifies an object in the center of a screen while locating a second object at the edge. The display speeds up as accuracy improves.

The trial design matters for interpretation. Participants completed ten sessions of 60 to 75 minutes over five to six weeks. A subset received booster sessions at 11 and 35 months. Those who completed more booster sessions showed larger reductions in risk.

The memory and reasoning arms improved on their trained tasks but did not show the same dementia-risk signal. That is the most important detail for anyone shopping for programs, and it is why we separate speed training from brain games in general. The National Institute on Aging funded the trial and publishes summaries of its findings.


An older man stands at a window concentrating on a phone call in soft morning light.

Do brain-game apps like Lumosity and BrainHQ really work?

Mostly no for memory loss, with one exception. Commercial brain games reliably improve the specific games you practice, and evidence that gains transfer to daily life is weak. The exception is speed-of-processing training, the ACTIVE exercise now sold in BrainHQ as Double Decision. Apps like Lumosity, CogniFit, and Elevate are better framed as mental activity than treatment.

The practical distinction is between practice effects and transfer. Getting faster at a matching game is a practice effect. Being able to recall whether you took a pill this morning is transfer, and most apps have not demonstrated it.

For a parent who already has memory loss, the bigger problem is adherence. Apps require remembering to open them, reading small text, and tapping accurately. We cover this trade-off in detail in our comparison of Velma and Lumosity for older adults.

If you want the clinical categories sorted out, read our guide to cognitive stimulation therapy vs brain games vs cognitive rehab. It explains what each aims to do and who delivers it.

How much cognitive training does a person need to see a benefit?

In the ACTIVE trial, benefit came from ten sessions of 60 to 75 minutes over five to six weeks. Booster sessions at 11 and 35 months added to the effect. Cognitive stimulation therapy trials used 14 sessions over 7 weeks, twice a week. For someone already losing memory, shorter daily sessions with ongoing maintenance beat occasional long ones.

The common thread across both evidence bases is maintenance. ACTIVE's booster sessions amplified the effect, and maintenance CST extended gains that otherwise faded within months.

A workable decision rule: for healthy adults, three sessions a week of 20 to 30 minutes on a screen is realistic. For a parent with MCI or dementia, a short daily session led by someone else is more likely to happen at all.

This is the gap Velma is built for. Sessions happen every day, a dedicated care manager supports the routine, and the schedule works around the person rather than the family. Our review of whether cognitive stimulation therapy actually works walks through the trial dosages in more detail.

What is the difference between normal forgetfulness, MCI, and dementia?

Normal forgetfulness means occasionally misplacing keys or blanking on a name that comes back later. Mild cognitive impairment means measurable decline, noticed by the person or family, that does not yet stop independent living. Dementia means decline severe enough to interfere with daily tasks like managing money, medications, or finding the way home.

The Alzheimer's Association notes that MCI raises the risk of progressing to dementia but is not guaranteed to progress. Some people stay stable for years, and some return to normal cognition.

Some warning signs go beyond normal aging. They include asking the same question repeatedly within an hour, getting lost on familiar routes, and trouble following a recipe or a TV plot. Any of these justifies a doctor's visit.

Stage also decides which program fits. A self-directed app suits normal aging. MCI calls for structure and tracking. Dementia calls for guided daily engagement and support for routines, which is where phone-based programs and CST groups earn their place.

Is there a treatment for mild cognitive impairment?

There is no FDA-approved drug that cures mild cognitive impairment, but MCI is treatable in the sense that its course can change. Some causes, like thyroid problems, sleep apnea, depression, and medication side effects, are reversible. For MCI due to Alzheimer's, anti-amyloid drugs, structured cognitive training, exercise, and vascular risk control can slow progression.

The first step is a medical workup to rule out reversible causes. Vitamin B12 deficiency, untreated hearing loss, and sedating medications are common and fixable contributors.

For amyloid-confirmed MCI, lecanemab and donanemab are approved for the earliest symptomatic stage, which includes MCI due to Alzheimer's. Eligibility requires a PET scan or spinal fluid test and regular MRI monitoring.

Cognitive training does not reverse MCI, but it can improve the trained skills and support independence. Pairing it with daily routine prompts, such as medication reminders, addresses the real-world problems that bring families to this search in the first place.

Which doctor diagnoses memory loss, and what tests are involved?

Start with a primary care physician, who can run a cognitive screen and order blood work during a Medicare annual wellness visit. Referral then goes to a neurologist, geriatrician, geriatric psychiatrist, or neuropsychologist. Testing typically includes a screening test like the MoCA or Mini-Cog, lab work, brain imaging, and sometimes several hours of neuropsychological testing.

Medicare Part B covers a cognitive assessment and a separate care planning visit after a diagnosis. Medicare.gov describes both services. Ask for both by name, because not every practice offers them automatically.

Bring a written list of specific changes, when they started, and current medications. Doctors diagnose faster when a family member describes concrete examples rather than a general worry.

What Medicare does not cover is ongoing cognitive wellness programs or brain training. Our guide to whether insurance covers cognitive support programs for seniors explains what is paid for and what is not. It also covers how Medicaid waivers and long-term care policies fit in.

Why should exercise and lifestyle sit alongside any cognitive program?

Because no cognitive program works alone. The 2024 Lancet Commission on dementia attributed roughly 45 percent of dementia cases to 14 modifiable risk factors. Those include hearing loss, high blood pressure, inactivity, social isolation, and poor sleep. Aerobic exercise raises BDNF, a protein linked to memory, and pairing movement with memory tasks is a low-cost dual-task approach.

The Lancet Commission on dementia prevention treats these as targets across the lifespan. Hearing aids, treating hypertension, and staying socially connected are among the highest-impact items for adults over 65.

Dual-task training is simple to try at home. Walk at a comfortable pace while naming animals alphabetically, or do seated marching while recalling the grocery list. Psychiatrist Daniel Amen has popularized this pairing, and it fits the broader exercise evidence.

On diet, the MIND and Mediterranean patterns are reasonable. The 2023 MIND randomized trial did not find a significant cognitive advantage over a standard calorie-controlled diet in three years. Sleep and blood pressure have stronger evidence, so start there.


A small group of older adults and a facilitator talk together in a bright community room.

Are there new Alzheimer's drugs or trials in 2026 worth asking a doctor about?

Yes, with realistic expectations: lecanemab (Leqembi) and donanemab (Kisunla) are FDA-approved anti-amyloid infusions for early Alzheimer's that modestly slow decline. They carry risks of brain swelling and bleeding that require MRI monitoring. Ask about eligibility, confirmed amyloid status, and trial enrollment. Trials targeting tau and inflammation continued into 2026.

The U.S. Food and Drug Administration granted lecanemab traditional approval in July 2023 and approved donanemab in July 2024. Both are limited to people with MCI or mild dementia and confirmed amyloid.

What did not work matters too. Several earlier anti-amyloid antibodies failed in late-stage trials, and even the approved drugs slow decline by months rather than stopping it. A frank conversation about expected benefit, infusion logistics, and cost is worth having.

If your parent is not eligible, that does not close off action. Cognitive engagement, exercise, hearing care, and vascular management remain available at every stage and at much lower cost.

How do you pick a program for healthy aging, MCI, or diagnosed dementia?

Healthy aging: a self-directed app with speed-of-processing training, used three times a week, plus exercise. MCI: a structured program with assessment, regular progress checks, and lifestyle changes, ideally alongside a physician. Diagnosed dementia: daily guided engagement at home or a cognitive stimulation group, with routine support and family alerts, because self-directed apps are rarely sustained.

Accessibility decides adherence more than content does. Check whether your parent can see the screen, hear the audio, and tap small targets. If any answer is no, a phone-based or in-person program will outlast an app.

Onboarding is the other filter. Ask how the first week works, who sets the schedule, and what happens if a session is missed. Velma's answer is a free first session, a care manager who sets the routine, and alerts to family when patterns change.

For a wider view of options across day programs, phone services, and apps, see our family guide to the best cognitive support programs for seniors. It sorts them by the job each one fills.

How did we compare these options?

We compared each option's published plan page, listed pricing or pricing model, and delivery format. We also weighed the strength of evidence behind its method and who it is designed for. We did not run our own study. Competitor prices change, so confirm them on each vendor's site before deciding.

How do you get started with Velma?

Book the free first session at heyvelma.com, then continue at $199 a month. That price covers daily cognitive sessions, a dedicated care manager, routine support, and family alerts. Your care manager sets a schedule around your parent's day, and you receive updates and alerts without needing to join each session.

There is no commitment for the first session. It is a chance to see how a daily phone session works for your parent. You can also ask the care manager any questions about how the program works.

Book your free first session with Velma

What do people also ask?

Is there a treatment for mild cognitive impairment?

No single cure exists, but MCI is treatable. Doctors first rule out reversible causes such as thyroid disease, B12 deficiency, sleep apnea, depression, and sedating medications. For MCI due to Alzheimer's with confirmed amyloid, lecanemab and donanemab can modestly slow decline. Structured cognitive training, aerobic exercise, hearing care, and blood pressure control support function at every stage.

What doctor diagnoses dementia or Alzheimer's?

A primary care physician usually screens first, using tests like the MoCA or Mini-Cog plus blood work, often during a Medicare annual wellness visit. For a formal diagnosis, they refer to a neurologist, geriatrician, geriatric psychiatrist, or neuropsychologist. That specialist may add brain imaging, amyloid testing, and several hours of neuropsychological testing.

How can I fight forgetfulness at home right now?

Keep one calendar and one notebook in a fixed spot, and use a labeled weekly pill organizer. Attach new habits to existing ones, like reviewing tomorrow's plan after dinner. Add 30 minutes of walking most days, treat hearing loss, protect sleep, and do a short daily cognitive session. Consistency beats intensity.

What is the difference between dementia and cognitive impairment?

Mild cognitive impairment means measurable decline in memory or thinking that the person or family notices but that does not stop independent living. Dementia means decline severe enough to interfere with daily tasks such as managing medications, money, or finding the way home. MCI raises dementia risk but does not always progress.

Which cognitive training program has the strongest evidence for reducing dementia risk?

Speed-of-processing training from the NIH-funded ACTIVE trial, sold commercially as BrainHQ's Double Decision. The ten-year follow-up reported a 29 percent lower rate of dementia in that group, and the 2026 twenty-year analysis found the lower risk persisted. Memory and reasoning training in the same trial did not show the same effect, and general brain games have not been tested this way.

Families comparing memory programs this week need one that matches the person's stage. It also has to get used every day. Our top pick is Velma, a daily phone-based cognitive program for older adults with early memory loss or Alzheimer's. It pairs AI assistants with a dedicated care manager for $199 a month, and the first session is free.

Velma is not a licensed therapy clinic, not a brain-game app, and not a substitute for a physician's diagnosis or treatment plan. BrainHQ, Lumosity, CogniFit, and cognitive stimulation therapy groups round out our list.

Key takeaways:

  • Velma costs $199 a month. That covers daily cognitive sessions, a dedicated care manager, routine support, and family alerts. The first session is free.

  • The NIH-funded ACTIVE trial gave 2,802 adults aged 65 and older ten training sessions over five to six weeks. The ten-year follow-up reported a 29 percent lower rate of dementia in the speed-of-processing group. The 2026 twenty-year analysis found the lower risk persisted.

  • Only speed-of-processing training carries that evidence. Memory and reasoning training in the same trial did not show a dementia-risk reduction. Generic brain games have not been tested the same way.

  • Mild cognitive impairment and dementia differ by independence. MCI means measurable decline without loss of daily function. Dementia means decline that interferes with tasks like managing medications or money.

  • The 2024 Lancet Commission attributed roughly 45 percent of dementia cases to 14 modifiable risk factors. Exercise, hearing care, and blood pressure control belong next to any cognitive program.


An adult daughter and her elderly father laugh together on a porch bench in afternoon light.

Try Velma Now

What are the best cognitive programs for memory loss in 2026?

The best cognitive programs for memory loss in 2026 are Velma, BrainHQ, Lumosity, CogniFit, and cognitive stimulation therapy groups. Velma leads for daily guided sessions with family alerts. BrainHQ offers the speed-of-processing training tested in the NIH ACTIVE study. Lumosity suits low-cost self-directed games, CogniFit suits assessment-based training, and CST groups suit in-person engagement.

  1. Velma: best when a parent needs daily guided sessions at home and the family needs updates

Velma runs structured cognitive sessions by phone every day. There is no app to learn, no screen to squint at, and no login to forget. An AI assistant leads the session and a dedicated care manager supports the routine.

Families receive regular updates and alerts when something changes, which matters most for adult children working full time. The sessions are research-backed and work around your parent's schedule.

One member, Dara, an independent retiree with Alzheimer's, doubled her attention and working memory in a few weeks. She started going to the gym and reported much less anxiety. Roy, a musician with early Alzheimer's, became more outgoing and rejoined social events, which eased the load on his wife.

The program costs $199 a month, less than a single in-person therapy session. The honest limit: Velma is not licensed cognitive rehabilitation, it does not diagnose, and it does not supervise anyone in person.

  1. BrainHQ: best when a cognitively healthy or mildly impaired adult wants the exact training type ACTIVE tested

BrainHQ, made by Posit Science, sells the commercial version of the useful field of view exercise from the ACTIVE trial. It is called Double Decision. That makes it the only consumer app whose core exercise sits inside a long-term dementia-risk study.

It is sold as a monthly or annual subscription. Published pricing has been $14 a month or $96 a year; confirm current pricing on brainhq.com before you buy.

The limit is that BrainHQ is fully self-directed on a screen. There is no human check-in, no family alert, and no routine support, so adherence falls on the user or the family.

  1. Lumosity: best when a self-sufficient adult wants inexpensive daily mental activity

Lumosity offers a free tier with a limited number of daily games and a paid premium subscription billed monthly or annually. The games are polished and cover attention, memory, flexibility, and problem solving.

The limit is evidence. In 2016 Lumos Labs paid a $2 million settlement to the Federal Trade Commission over unsupported claims that its games delayed cognitive impairment. It remains a reasonable way to stay mentally active, not a treatment for memory loss.

  1. CogniFit: best when you want a baseline assessment before training

CogniFit starts with a cognitive assessment, then assigns personalized training across attention, memory, perception, and reasoning. Some researchers use its assessment tools, which gives it more structure than a game library.

It is subscription based, with full training behind the paywall; check cognifit.com for current plans. The limit is the same as other apps: screen-based, self-directed, and no human support for a person who forgets to log in.

  1. Cognitive stimulation therapy groups: best when a person with mild to moderate dementia can attend in person

Cognitive stimulation therapy, or CST, is a 14-session, 7-week group program led by trained facilitators. It has Cochrane-reviewed evidence for improving cognition and quality of life in mild to moderate dementia. It is offered through some memory clinics, adult day programs, and community organizations.

Cost ranges from free to a per-session fee depending on the provider. The limit is access: availability in the United States is patchy, transportation is required, and gains fade once the sessions end.

Option

Best for

Pricing or format

Standout limit

Velma

Daily guided sessions at home plus family alerts

$199 a month; first session free

Not licensed therapy; does not diagnose or supervise in person

BrainHQ

Speed-of-processing training tested in ACTIVE

Monthly or annual subscription; confirm on brainhq.com

Self-directed on a screen; no human support

Lumosity

Low-cost daily mental activity

Free tier plus premium subscription

2016 FTC settlement over unsupported claims; no dementia evidence

CogniFit

Assessment-first personalized training

Subscription; confirm on cognifit.com

Requires logins and screen use; no family updates

CST groups

In-person group engagement for mild to moderate dementia

14 sessions over 7 weeks; free to per-session fee

Limited US availability; gains fade after sessions stop

What did the 20-year NIH ACTIVE study actually find?

The ACTIVE trial enrolled 2,802 adults aged 65 and older and tested three training types: memory, reasoning, and speed of processing. Ten-year results reported a 29 percent lower rate of dementia in the speed-of-processing group. The 2026 twenty-year follow-up by NIH-funded researchers found that this reduced risk persisted across two decades.

Speed-of-processing training used a task called useful field of view. A participant identifies an object in the center of a screen while locating a second object at the edge. The display speeds up as accuracy improves.

The trial design matters for interpretation. Participants completed ten sessions of 60 to 75 minutes over five to six weeks. A subset received booster sessions at 11 and 35 months. Those who completed more booster sessions showed larger reductions in risk.

The memory and reasoning arms improved on their trained tasks but did not show the same dementia-risk signal. That is the most important detail for anyone shopping for programs, and it is why we separate speed training from brain games in general. The National Institute on Aging funded the trial and publishes summaries of its findings.


An older man stands at a window concentrating on a phone call in soft morning light.

Do brain-game apps like Lumosity and BrainHQ really work?

Mostly no for memory loss, with one exception. Commercial brain games reliably improve the specific games you practice, and evidence that gains transfer to daily life is weak. The exception is speed-of-processing training, the ACTIVE exercise now sold in BrainHQ as Double Decision. Apps like Lumosity, CogniFit, and Elevate are better framed as mental activity than treatment.

The practical distinction is between practice effects and transfer. Getting faster at a matching game is a practice effect. Being able to recall whether you took a pill this morning is transfer, and most apps have not demonstrated it.

For a parent who already has memory loss, the bigger problem is adherence. Apps require remembering to open them, reading small text, and tapping accurately. We cover this trade-off in detail in our comparison of Velma and Lumosity for older adults.

If you want the clinical categories sorted out, read our guide to cognitive stimulation therapy vs brain games vs cognitive rehab. It explains what each aims to do and who delivers it.

How much cognitive training does a person need to see a benefit?

In the ACTIVE trial, benefit came from ten sessions of 60 to 75 minutes over five to six weeks. Booster sessions at 11 and 35 months added to the effect. Cognitive stimulation therapy trials used 14 sessions over 7 weeks, twice a week. For someone already losing memory, shorter daily sessions with ongoing maintenance beat occasional long ones.

The common thread across both evidence bases is maintenance. ACTIVE's booster sessions amplified the effect, and maintenance CST extended gains that otherwise faded within months.

A workable decision rule: for healthy adults, three sessions a week of 20 to 30 minutes on a screen is realistic. For a parent with MCI or dementia, a short daily session led by someone else is more likely to happen at all.

This is the gap Velma is built for. Sessions happen every day, a dedicated care manager supports the routine, and the schedule works around the person rather than the family. Our review of whether cognitive stimulation therapy actually works walks through the trial dosages in more detail.

What is the difference between normal forgetfulness, MCI, and dementia?

Normal forgetfulness means occasionally misplacing keys or blanking on a name that comes back later. Mild cognitive impairment means measurable decline, noticed by the person or family, that does not yet stop independent living. Dementia means decline severe enough to interfere with daily tasks like managing money, medications, or finding the way home.

The Alzheimer's Association notes that MCI raises the risk of progressing to dementia but is not guaranteed to progress. Some people stay stable for years, and some return to normal cognition.

Some warning signs go beyond normal aging. They include asking the same question repeatedly within an hour, getting lost on familiar routes, and trouble following a recipe or a TV plot. Any of these justifies a doctor's visit.

Stage also decides which program fits. A self-directed app suits normal aging. MCI calls for structure and tracking. Dementia calls for guided daily engagement and support for routines, which is where phone-based programs and CST groups earn their place.

Is there a treatment for mild cognitive impairment?

There is no FDA-approved drug that cures mild cognitive impairment, but MCI is treatable in the sense that its course can change. Some causes, like thyroid problems, sleep apnea, depression, and medication side effects, are reversible. For MCI due to Alzheimer's, anti-amyloid drugs, structured cognitive training, exercise, and vascular risk control can slow progression.

The first step is a medical workup to rule out reversible causes. Vitamin B12 deficiency, untreated hearing loss, and sedating medications are common and fixable contributors.

For amyloid-confirmed MCI, lecanemab and donanemab are approved for the earliest symptomatic stage, which includes MCI due to Alzheimer's. Eligibility requires a PET scan or spinal fluid test and regular MRI monitoring.

Cognitive training does not reverse MCI, but it can improve the trained skills and support independence. Pairing it with daily routine prompts, such as medication reminders, addresses the real-world problems that bring families to this search in the first place.

Which doctor diagnoses memory loss, and what tests are involved?

Start with a primary care physician, who can run a cognitive screen and order blood work during a Medicare annual wellness visit. Referral then goes to a neurologist, geriatrician, geriatric psychiatrist, or neuropsychologist. Testing typically includes a screening test like the MoCA or Mini-Cog, lab work, brain imaging, and sometimes several hours of neuropsychological testing.

Medicare Part B covers a cognitive assessment and a separate care planning visit after a diagnosis. Medicare.gov describes both services. Ask for both by name, because not every practice offers them automatically.

Bring a written list of specific changes, when they started, and current medications. Doctors diagnose faster when a family member describes concrete examples rather than a general worry.

What Medicare does not cover is ongoing cognitive wellness programs or brain training. Our guide to whether insurance covers cognitive support programs for seniors explains what is paid for and what is not. It also covers how Medicaid waivers and long-term care policies fit in.

Why should exercise and lifestyle sit alongside any cognitive program?

Because no cognitive program works alone. The 2024 Lancet Commission on dementia attributed roughly 45 percent of dementia cases to 14 modifiable risk factors. Those include hearing loss, high blood pressure, inactivity, social isolation, and poor sleep. Aerobic exercise raises BDNF, a protein linked to memory, and pairing movement with memory tasks is a low-cost dual-task approach.

The Lancet Commission on dementia prevention treats these as targets across the lifespan. Hearing aids, treating hypertension, and staying socially connected are among the highest-impact items for adults over 65.

Dual-task training is simple to try at home. Walk at a comfortable pace while naming animals alphabetically, or do seated marching while recalling the grocery list. Psychiatrist Daniel Amen has popularized this pairing, and it fits the broader exercise evidence.

On diet, the MIND and Mediterranean patterns are reasonable. The 2023 MIND randomized trial did not find a significant cognitive advantage over a standard calorie-controlled diet in three years. Sleep and blood pressure have stronger evidence, so start there.


A small group of older adults and a facilitator talk together in a bright community room.

Are there new Alzheimer's drugs or trials in 2026 worth asking a doctor about?

Yes, with realistic expectations: lecanemab (Leqembi) and donanemab (Kisunla) are FDA-approved anti-amyloid infusions for early Alzheimer's that modestly slow decline. They carry risks of brain swelling and bleeding that require MRI monitoring. Ask about eligibility, confirmed amyloid status, and trial enrollment. Trials targeting tau and inflammation continued into 2026.

The U.S. Food and Drug Administration granted lecanemab traditional approval in July 2023 and approved donanemab in July 2024. Both are limited to people with MCI or mild dementia and confirmed amyloid.

What did not work matters too. Several earlier anti-amyloid antibodies failed in late-stage trials, and even the approved drugs slow decline by months rather than stopping it. A frank conversation about expected benefit, infusion logistics, and cost is worth having.

If your parent is not eligible, that does not close off action. Cognitive engagement, exercise, hearing care, and vascular management remain available at every stage and at much lower cost.

How do you pick a program for healthy aging, MCI, or diagnosed dementia?

Healthy aging: a self-directed app with speed-of-processing training, used three times a week, plus exercise. MCI: a structured program with assessment, regular progress checks, and lifestyle changes, ideally alongside a physician. Diagnosed dementia: daily guided engagement at home or a cognitive stimulation group, with routine support and family alerts, because self-directed apps are rarely sustained.

Accessibility decides adherence more than content does. Check whether your parent can see the screen, hear the audio, and tap small targets. If any answer is no, a phone-based or in-person program will outlast an app.

Onboarding is the other filter. Ask how the first week works, who sets the schedule, and what happens if a session is missed. Velma's answer is a free first session, a care manager who sets the routine, and alerts to family when patterns change.

For a wider view of options across day programs, phone services, and apps, see our family guide to the best cognitive support programs for seniors. It sorts them by the job each one fills.

How did we compare these options?

We compared each option's published plan page, listed pricing or pricing model, and delivery format. We also weighed the strength of evidence behind its method and who it is designed for. We did not run our own study. Competitor prices change, so confirm them on each vendor's site before deciding.

How do you get started with Velma?

Book the free first session at heyvelma.com, then continue at $199 a month. That price covers daily cognitive sessions, a dedicated care manager, routine support, and family alerts. Your care manager sets a schedule around your parent's day, and you receive updates and alerts without needing to join each session.

There is no commitment for the first session. It is a chance to see how a daily phone session works for your parent. You can also ask the care manager any questions about how the program works.

Book your free first session with Velma

What do people also ask?

Is there a treatment for mild cognitive impairment?

No single cure exists, but MCI is treatable. Doctors first rule out reversible causes such as thyroid disease, B12 deficiency, sleep apnea, depression, and sedating medications. For MCI due to Alzheimer's with confirmed amyloid, lecanemab and donanemab can modestly slow decline. Structured cognitive training, aerobic exercise, hearing care, and blood pressure control support function at every stage.

What doctor diagnoses dementia or Alzheimer's?

A primary care physician usually screens first, using tests like the MoCA or Mini-Cog plus blood work, often during a Medicare annual wellness visit. For a formal diagnosis, they refer to a neurologist, geriatrician, geriatric psychiatrist, or neuropsychologist. That specialist may add brain imaging, amyloid testing, and several hours of neuropsychological testing.

How can I fight forgetfulness at home right now?

Keep one calendar and one notebook in a fixed spot, and use a labeled weekly pill organizer. Attach new habits to existing ones, like reviewing tomorrow's plan after dinner. Add 30 minutes of walking most days, treat hearing loss, protect sleep, and do a short daily cognitive session. Consistency beats intensity.

What is the difference between dementia and cognitive impairment?

Mild cognitive impairment means measurable decline in memory or thinking that the person or family notices but that does not stop independent living. Dementia means decline severe enough to interfere with daily tasks such as managing medications, money, or finding the way home. MCI raises dementia risk but does not always progress.

Which cognitive training program has the strongest evidence for reducing dementia risk?

Speed-of-processing training from the NIH-funded ACTIVE trial, sold commercially as BrainHQ's Double Decision. The ten-year follow-up reported a 29 percent lower rate of dementia in that group, and the 2026 twenty-year analysis found the lower risk persisted. Memory and reasoning training in the same trial did not show the same effect, and general brain games have not been tested this way.

Suggested Article: